PEOPLEBIO, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,680 KRW | +0.75% |
|
+0.56% | -12.85% |
| 2023 | PeopleBio, Inc. announced that it has received KRW 5.399992647 billion in funding | CI |
| 2023 | Peoplebio to Raise 5.4 Billion Won From Shares Issuance | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
PeopleBio Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical supplies. The Company's main products include oligomerized beta-amyloid (OAβ) test systems, and others. The Companyâs multimer detection system (MDS) is sandwich assay using capturing antibodies and epitope-overlapping detection antibodies for the detection of only oligomers or multimers from monomers in protein-misfolding diseases. The Company sells its products in domestic and overseas markets.
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.85% | 41.65M | |
| -4.67% | 12.32B | |
| -5.19% | 8.07B | |
| +9.45% | 5.91B | |
| +28.50% | 5.52B | |
| -8.09% | 4.21B | |
| +13.49% | 2.73B | |
| -1.34% | 2.43B | |
| +32.24% | 2.29B | |
| -3.55% | 1.89B |
- Stock Market
- Equities
- A304840 Stock
- News PeopleBio, Inc.
- Peoplebio to Raise 5.4 Billion Won From Shares Issuance